Danés, principal investigator of the Cancer and Stem Cell Biology Lab at the Champalimaud Foundation, in Lisbon, has shown ...

Risk factors for secondary skin cancer after blood or marrow transplant include those who had treatment with a monoclonal ...

McDermott says that he started seeing a dermatologist when he was in his 20s at the recommendation of his parents.

Basal cell carcinoma (BCC) is an epithelial tumour of the skin. It seldom metastasizes, but has the potential for local invasion and destruction. It usually occurs as one or several small pearly ...

Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumors in particular can be difficult to treat surgically. A ...

Reported recurrence rates of lentigo maligna treated with Mohs micrographic surgery have ranged from 0.5 to 30.0% in the ...

Percentage of biopsies with a diagnosis of cutaneous Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC), or melanoma (including in situ disease) in which the pathologist communicates results ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Jan. 27, 2025 — Basal cell ... prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is ... Study Traces Ebola's Route to the Skin Surface Jan. 1 ...

T-VEC enables BCC resectability in 50% of cases, showing promise as a neoadjuvant therapy with mild side effects.

This finding of a predominance of basal-cell carcinoma in irradiated skin of the face has recently ... Pathological histology of chronic x-ray dermatitis and early x-ray carcinoma.